Literature DB >> 1353377

Antidepressant-like effects of dopamine agonists in an animal model of depression.

R Muscat1, M Papp, P Willner.   

Abstract

Chronic exposure to mild unpredictable stress (CMS) has previously been found to cause an antidepressant-reversible decrease in the consumption of palatable sweet solutions. There is evidence that the effect of antidepressants in this model is mediated by an increase in transmission at dopamine (DA) synpases. The present study investigated whether another treatment known to increase the functional responsiveness of DA systems, intermittent administration of DA agonists, would have antidepressant-like effects. In three experiments in rats, CMS-induced decreases in sucrose consumption were reversed by three to four twice-weekly injections of quinpirole (100-200 micrograms/kg) or bromocriptine (2.5 mg/kg). The effects lasted for several weeks, and when they waned, could be reinstated by a single additional injection of quinpirole. As with tricyclic antidepressants, the effect of quinpirole was reversed by raclopride, administered acutely immediately prior to a sucrose consumption test; there were no changes in sucrose intake in nonstressed control animals. The results suggest that intermittent administration of DA agonists merits investigation as a novel strategy for the treatment of depression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353377     DOI: 10.1016/0006-3223(92)90119-k

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  25 in total

1.  Blunted accumbal dopamine response to cocaine following chronic social stress in female rats: exploring a link between depression and drug abuse.

Authors:  Akiko Shimamoto; Joseph F Debold; Elizabeth N Holly; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2011-06-03       Impact factor: 4.530

2.  Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects.

Authors:  Lin Pei; Shupeng Li; Min Wang; Mustansir Diwan; Hymie Anisman; Paul J Fletcher; José N Nobrega; Fang Liu
Journal:  Nat Med       Date:  2010-11-28       Impact factor: 53.440

3.  Lack of persistent effects of ketamine in rodent models of depression.

Authors:  Piotr Popik; Tomasz Kos; Magdalena Sowa-Kućma; Gabriel Nowak
Journal:  Psychopharmacology (Berl)       Date:  2008-05-07       Impact factor: 4.530

4.  Beneficial effects of exercise and its molecular mechanisms on depression in rats.

Authors:  Hang Zheng; Yanyou Liu; Wei Li; Bo Yang; Dengbang Chen; Xiaojia Wang; Zhou Jiang; Hongxing Wang; Zhengrong Wang; G Cornelisson; F Halberg
Journal:  Behav Brain Res       Date:  2005-11-11       Impact factor: 3.332

Review 5.  Depression in Parkinson's disease. Pharmacological characteristics and treatment.

Authors:  T Tom; J L Cummings
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

6.  Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample.

Authors:  Alden L Gross; Joseph J Gallo; William W Eaton
Journal:  Cancer Causes Control       Date:  2009-11-03       Impact factor: 2.506

7.  Postpartum Lactation-Mediated Behavioral Outcomes and Drug Responses in a Spontaneous Mouse Model of Obsessive-Compulsive Disorder.

Authors:  Swarup Mitra; McKenzie Mucha; Savanah Owen; Abel Bult-Ito
Journal:  ACS Chem Neurosci       Date:  2017-10-05       Impact factor: 4.418

8.  Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

Authors:  P Willner; S Lappas; S Cheeta; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

10.  Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.

Authors:  Kouhei Kitagawa; Yoshihisa Kitamura; Toshiaki Miyazaki; Junya Miyaoka; Hiromu Kawasaki; Masato Asanuma; Toshiaki Sendo; Yutaka Gomita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.